Treatment of Cognitive Deficits in Schizophrenia With Atomoxetine: A Case Report
J Clin Psychiatry 2007;68(12):1988-1989 [letter]
© Copyright 2017 Physicians Postgraduate Press, Inc.
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Schizophrenia patients have deficits in attention, concentration, and information processing that result in significant functional impairment.1 Atomoxetine, a novel cognitive enhancer that can reduce executive function deficits,2 has been postulated to potentially treat these deficits in schizophrenia.3 We report a patient with schizophrenia whose cognitive functioning improved after adjunctive treatment with atomoxetine.